We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Monoclonal Antibodies: Making Cancer a Target
Video

Monoclonal Antibodies: Making Cancer a Target

Monoclonal Antibodies: Making Cancer a Target
Video

Monoclonal Antibodies: Making Cancer a Target

Monoclonal antibodies, like the drugs Avastin (bevacizumab), Herceptin (trastuzumab), and Rituxin (rituximab), are effective in treating a wide range of cancer types such as lung cancer, breast cancer, lymphoma, and others. By binding to cancer antigens, monoclonal antibodies mark the cells for destruction by the immune system. Clinical trials of more monoclonal antibodies for additional cancer types are ongoing.

Advertisement